Call Directions Website Contact the school

3dheals Healthcare 3D Printing Ecosystem and Innovation Platform, SF based company, focusing on curating high https://linktr.ee/3dheals

Print a blood vessel you can actually suture. A UC San Diego team 3D-prints patient-specific vascular grafts with an AI-...
10/12/2026

Print a blood vessel you can actually suture. A UC San Diego team 3D-prints patient-specific vascular grafts with an AI-tuned bioink, built for low-cost microsurgery training. https://doi.org/10.1002/smll.75497

10/12/2026

The best technology in the room is often the reason a startup fails.

That's the pattern Jim West sees most across the life-science companies he accelerates. Not weak science — a platform that can do everything, pointed at nothing in particular. In his words:

"The big problems that we see companies struggling with, even if they don't know it, is focus … it's gotta go somewhere, somewhere specific that you can build your business off of."

West leads BioTools Innovator, the nonprofit accelerator for life-science tools and diagnostics. Narrowing a do-everything platform down to one go-to-market application is, he says, the single biggest thing his team helps founders with.

If you're building on a platform technology, have this conversation before your next raise.

Episode 128 of The Lattice Podcast, powered by 3DHEALS.
https://3dheals.com/episode-128-biotools-can-beat-moonshots-with-jim-west/

A tissue expander that inflates itself, no needles. A 4D-printed hydrogel expander swells over weeks on its own, aiming ...
10/09/2026

A tissue expander that inflates itself, no needles. A 4D-printed hydrogel expander swells over weeks on its own, aiming to replace the painful saline balloon in breast reconstruction.

10/09/2026

Everyone wants to fund the next miracle drug. Jim West says that's the worse bet.

Biotech is one shot at the plate: a three-to-five percent chance of a return, a swing at 100X, and years of regulatory risk. Life-science tools trade that for a five-to-ten-times return, better odds, no regulatory cliff, and a five-year horizon. Less glamorous — far more reliable.

West has run both plays. He co-founded and sold Clara Biotech, and now leads BioTools Innovator, the nonprofit accelerator for life-science tools and diagnostics. In his words:

"If you want to do the therapeutic home run grand slam sort of investing … you get one shot at plate, stay in biotech. The life science tools is not your place."

If you allocate to medtech, diagnostics, or research tools — or you're building in the space — give this one 28 minutes.

Episode 128 of The Lattice Podcast, powered by 3DHEALS.
https://3dheals.com/episode-128-biotools-can-beat-moonshots-with-jim-west/

VCU undergraduate Jazlyn Lopez Silva is refining a polymer 3D-printing material to be safe for implantable devices, with...
10/08/2026

VCU undergraduate Jazlyn Lopez Silva is refining a polymer 3D-printing material to be safe for implantable devices, with fibroblast testing as the next step - a look at early-stage academic work on implant biomaterials. https://sl1nk.com/fdq6mac

Address

901 Mission Street #105
San Francisco, CA
94103

Alerts

Be the first to know and let us send you an email when 3dheals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The School

Send a message to 3dheals:

Shortcuts

Share

Category